Credit rating agency, CRISIL has assigned rating to Lincoln Pharmaceuticals’ bank facilities worth Rs 93.41 crore. The agency has assigned ‘A- /Stable’ rating to the company’s long term bank loan facilities and ‘A2+’ rating to short term bank loan facilities.
Lincoln Pharmaceuticals is engaged in the manufacture and marketing of affordable therapeutic products. The product range of the company includes Tablets, Capsules, Injectable, Syrups and Ointments.